dry eye disease

NASHVILLE, Tenn., August 6, 2026 Harrow Inc. announced it has entered into a definitive agreement to acquire the global...

HONG KONG, August 5, 2026 Insilico Medicine has announced the nomination of ISM9077 as its 32nd Preclinical Candidate (PCC)...

Oculis, Zug, Switzerland, June 9, 2026 Oculis announced that the first patient has been randomized in the PREDICT-1 registrational...

SINGAPORE, May 16, 2026 Researchers at the National University of Singapore have developed a groundbreaking plant-based eye drop technology...

Tokyo, Japan – November 12, 2025 — Waseda University researchers disclosed results from the world’s first time-course observation of...

October 14, 2025 | Zug, Switzerland — Oculis Holding AG (Nasdaq: OCS), a global biopharmaceutical company advancing therapies for...